Ressaix, Belgium

Xavier Wilputte

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ion Beam Applications S.a.. Active years: 2018.


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Xavier Wilputte in Radioisotope Production

Introduction

Xavier Wilputte is a notable inventor based in Ressaix, Belgium. He has made significant contributions to the field of radioisotope production, showcasing his expertise through innovative methods and installations.

Latest Patents

Wilputte holds a patent for a process and installation for producing radioisotopes. This invention involves a method that includes irradiating a volume of radioisotope-precursor fluid contained in a sealed cell of a target using a beam of particles produced by a particle accelerator. The method allows for the internal pressure in the sealed cell to vary freely during irradiation, with specific parameters influencing this variation. The invention also includes an installation designed to implement this method effectively.

Career Highlights

Xavier Wilputte is associated with Ion Beam Applications S.A., a company that specializes in advanced technologies for the production of radioisotopes. His work has contributed to advancements in medical and industrial applications of radioisotopes, enhancing their availability and efficiency.

Collaborations

Wilputte has collaborated with notable colleagues, including Eric Kral and Michel Ghyoot. Their combined expertise has furthered the development of innovative solutions in the field of radioisotope production.

Conclusion

Xavier Wilputte's contributions to the field of radioisotope production through his innovative patent and collaborations highlight his role as a significant inventor in this specialized area. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…